Literature DB >> 25339801

Impact of psychological stress on irritable bowel syndrome.

Hong-Yan Qin1, Chung-Wah Cheng1, Xu-Dong Tang1, Zhao-Xiang Bian1.   

Abstract

Psychological stress is an important factor for the development of irritable bowel syndrome (IBS). More and more clinical and experimental evidence showed that IBS is a combination of irritable bowel and irritable brain. In the present review we discuss the potential role of psychological stress in the pathogenesis of IBS and provide comprehensive approaches in clinical treatment. Evidence from clinical and experimental studies showed that psychological stresses have marked impact on intestinal sensitivity, motility, secretion and permeability, and the underlying mechanism has a close correlation with mucosal immune activation, alterations in central nervous system, peripheral neurons and gastrointestinal microbiota. Stress-induced alterations in neuro-endocrine-immune pathways acts on the gut-brain axis and microbiota-gut-brain axis, and cause symptom flare-ups or exaggeration in IBS. IBS is a stress-sensitive disorder, therefore, the treatment of IBS should focus on managing stress and stress-induced responses. Now, non-pharmacological approaches and pharmacological strategies that target on stress-related alterations, such as antidepressants, antipsychotics, miscellaneous agents, 5-HT synthesis inhibitors, selective 5-HT reuptake inhibitors, and specific 5-HT receptor antagonists or agonists have shown a critical role in IBS management. A integrative approach for IBS management is a necessary.

Entities:  

Keywords:  Immune activation; Irritable bowel syndrome; Microbiota-gut-brain axis; Psychological stress

Mesh:

Year:  2014        PMID: 25339801      PMCID: PMC4202343          DOI: 10.3748/wjg.v20.i39.14126

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

Authors:  Bin Feng; Jun Ho La; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

Review 3.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

4.  Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective.

Authors:  Ami D Sperber; Douglas A Drossman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

5.  The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.

Authors:  Philip M Brown; Douglas A Drossman; Alastair J J Wood; Gary A Cline; Kenny S Frazier; Jessica I Jackson; Johanna Bronner; Joel Freiman; Brian Zambrowicz; Arthur Sands; Michael D Gershon
Journal:  Gastroenterology       Date:  2011-05-18       Impact factor: 22.682

Review 6.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

7.  Visceral hyperalgesia induced by neonatal maternal separation is associated with nerve growth factor-mediated central neuronal plasticity in rat spinal cord.

Authors:  E K Y Chung; X-J Zhang; H-X Xu; J J Y Sung; Z-X Bian
Journal:  Neuroscience       Date:  2007-09-08       Impact factor: 3.590

Review 8.  Psychophysiology of visceral pain in IBS and health.

Authors:  Frauke Musial; Winfried Häuser; Jost Langhorst; Gustav Dobos; Paul Enck
Journal:  J Psychosom Res       Date:  2008-04-28       Impact factor: 3.006

9.  Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.

Authors:  Siobhain M O'Mahony; Julian R Marchesi; Paul Scully; Caroline Codling; Anne-Marie Ceolho; Eamonn M M Quigley; John F Cryan; Timothy G Dinan
Journal:  Biol Psychiatry       Date:  2008-08-23       Impact factor: 13.382

10.  Brain-gut-microbe communication in health and disease.

Authors:  Sue Grenham; Gerard Clarke; John F Cryan; Timothy G Dinan
Journal:  Front Physiol       Date:  2011-12-07       Impact factor: 4.566

View more
  73 in total

1.  A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.

Authors:  Bu'Hussain Hayee; Kerry-Lee Watson; Sanchika Campbell; Anna Simpson; Emma Farrell; Penelope Hutchings; Patricia Macedo; Felicity Perrin; Kevin Whelan; Caroline Elston
Journal:  United European Gastroenterol J       Date:  2019-08       Impact factor: 4.623

Review 2.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

3.  Perceived Stress in Patients with Common Gastrointestinal Disorders: Associations with Quality of Life, Symptoms and Disease Management.

Authors:  Joel S Edman; Jeffrey M Greeson; Rhonda S Roberts; Adam B Kaufman; Donald I Abrams; Rowena J Dolor; Ruth Q Wolever
Journal:  Explore (NY)       Date:  2016-12-16       Impact factor: 1.775

Review 4.  Irritable bowel syndrome, the microbiota and the gut-brain axis.

Authors:  Hans Raskov; Jakob Burcharth; Hans-Christian Pommergaard; Jacob Rosenberg
Journal:  Gut Microbes       Date:  2016-07-29

Review 5.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

Review 6.  Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.

Authors:  Carlos Teruel; Elena Garrido; Francisco Mesonero
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

7.  Prevalence and impact of self-reported irritable bowel symptoms in the general population.

Authors:  K Van den Houte; F Carbone; J Pannemans; M Corsetti; B Fischler; H Piessevaux; J Tack
Journal:  United European Gastroenterol J       Date:  2018-12-22       Impact factor: 4.623

Review 8.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

9.  Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress.

Authors:  Tiffany L Carson; Fuchenchu Wang; Xiangqin Cui; Bradford E Jackson; William J Van Der Pol; Elliot J Lefkowitz; Casey Morrow; Monica L Baskin
Journal:  Psychosom Med       Date:  2018-09       Impact factor: 4.312

10.  Nod-like receptors are critical for gut-brain axis signalling in mice.

Authors:  Matteo M Pusceddu; Mariana Barboza; Ciara E Keogh; Melinda Schneider; Patricia Stokes; Jessica A Sladek; Hyun Jung D Kim; Cristina Torres-Fuentes; Lily R Goldfild; Shane E Gillis; Ingrid Brust-Mascher; Gonzalo Rabasa; Kyle A Wong; Carlito Lebrilla; Mariana X Byndloss; Charles Maisonneuve; Andreas J Bäumler; Dana J Philpott; Richard L Ferrero; Kim E Barrett; Colin Reardon; Mélanie G Gareau
Journal:  J Physiol       Date:  2019-11-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.